Alessia Lodi

4.6k total citations
67 papers, 2.1k citations indexed

About

Alessia Lodi is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Alessia Lodi has authored 67 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 20 papers in Cancer Research and 10 papers in Hematology. Recurrent topics in Alessia Lodi's work include Metabolomics and Mass Spectrometry Studies (19 papers), Cancer, Hypoxia, and Metabolism (19 papers) and Histone Deacetylase Inhibitors Research (9 papers). Alessia Lodi is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (19 papers), Cancer, Hypoxia, and Metabolism (19 papers) and Histone Deacetylase Inhibitors Research (9 papers). Alessia Lodi collaborates with scholars based in United States, United Kingdom and Italy. Alessia Lodi's co-authors include Stefano Tiziani, Sabrina M. Ronen, Mark R. Viant, Ulrich L. Günther, Mónica Gumá, Christopher M. Bunce, Davide Ruggero, John T. Cunningham, Anne N. Murphy and Yael Vodovotz and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Alessia Lodi

65 papers receiving 2.1k citations

Peers

Alessia Lodi
Stefano Tiziani United States
G.M. Anantharamaiah United States
Mariam Aghajan United States
Marie H. Hanigan United States
Mika Hilvo Finland
Yuan Zhou China
Maryanne Covington United States
Celina Edelstein United States
Stefano Tiziani United States
Alessia Lodi
Citations per year, relative to Alessia Lodi Alessia Lodi (= 1×) peers Stefano Tiziani

Countries citing papers authored by Alessia Lodi

Since Specialization
Citations

This map shows the geographic impact of Alessia Lodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Lodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Lodi more than expected).

Fields of papers citing papers by Alessia Lodi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Lodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Lodi. The network helps show where Alessia Lodi may publish in the future.

Co-authorship network of co-authors of Alessia Lodi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Lodi. A scholar is included among the top collaborators of Alessia Lodi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Lodi. Alessia Lodi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Ran, Liang Zhang, Hiroki Akiyama, et al.. (2025). Protocol for isolation of lipid droplets and mitochondria from acute myeloid leukemia cells for lipidomic analysis. STAR Protocols. 6(4). 104257–104257.
2.
Rizzotto, Lara, Anna Tessari, Rosa Visone, et al.. (2025). RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferation. Journal of Experimental & Clinical Cancer Research. 44(1). 259–259. 1 indexed citations
3.
Gorgoglione, Ruggiero, et al.. (2025). Targeting Metabolic and Epigenetic Vulnerabilities in Glioblastoma with SN-38 and Rabusertib Combination Therapy. International Journal of Molecular Sciences. 26(2). 474–474. 3 indexed citations
4.
Kelly, William, Virginia Kaklamani, Kate Lathrop, et al.. (2024). Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial. Nature Communications. 15(1). 6707–6707. 12 indexed citations
5.
Collins, Meghan, Ruggiero Gorgoglione, Xingxin Pan, et al.. (2024). Exploration of the intracellular chiral metabolome in pediatric BCP-ALL: a pilot study investigating the metabolic phenotype of IgH locus aberrations. Frontiers in Oncology. 14. 1413264–1413264. 1 indexed citations
6.
Zhang, Liang, Ran Zhao, Hiroki Akiyama, et al.. (2024). Targeting Lipid Droplet Biogenesis to Enhance Ferroptosis in Acute Myeloid Leukemia. Blood. 144(Supplement 1). 1400–1400.
7.
Gorgoglione, Ruggiero, Amer Ahmed, Angelo Vozza, et al.. (2023). Generation of a Yeast Cell Model Potentially Useful to Identify the Mammalian Mitochondrial N-Acetylglutamate Transporter. Biomolecules. 13(5). 808–808. 3 indexed citations
8.
Lodi, Alessia, Renu Pandey, Ayon Bhattacharya, et al.. (2022). Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide. Frontiers in Oncology. 12. 900082–900082. 7 indexed citations
9.
Lu, Xiyuan, Achinto Saha, Atul Rathore, et al.. (2022). Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry. iScience. 25(5). 104221–104221. 7 indexed citations
11.
Coras, Roxana, Sara Brin Rosenthal, Shannon Sweeney, et al.. (2018). Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis. Arthritis Research & Therapy. 20(1). 164–164. 38 indexed citations
12.
Baran, Natalia, Shannon Sweeney, Alessia Lodi, et al.. (2017). Inhibition of Oxphos with Iacs-010759 Depletes AML Leukemia Initiating Cells (LIC) in Vitro and Improves Survival in Pre-Clinical AML Models. Blood. 130. 1350–1350. 1 indexed citations
13.
Lodi, Alessia, Achinto Saha, Xiyuan Lu, et al.. (2017). Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism. npj Precision Oncology. 1(1). 67 indexed citations
14.
Cunningham, John T., et al.. (2014). Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer. Cell. 157(5). 1088–1103. 180 indexed citations
15.
Cunningham, John T., et al.. (2014). Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer. Cell. 158(3). 689–689. 3 indexed citations
16.
Gumá, Mónica, Elsa Sánchez‐López, Alessia Lodi, et al.. (2014). Choline kinase inhibition in rheumatoid arthritis. Annals of the Rheumatic Diseases. 74(7). 1399–1407. 69 indexed citations
17.
Tiziani, Stefano, Alessia Lodi, Farhat L. Khanim, et al.. (2009). Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines. PLoS ONE. 4(1). e4251–e4251. 97 indexed citations
18.
Tiziani, Stefano, Alessia Lodi, Christian Ludwig, Helen Parsons, & Mark R. Viant. (2008). Effects of the application of different window functions and projection methods on processing of 1H J-resolved nuclear magnetic resonance spectra for metabolomics. Analytica Chimica Acta. 610(1). 80–88. 23 indexed citations
19.
Lodi, Alessia, Amir Abduljalil, & Yael Vodovotz. (2007). Characterization of water distribution in bread during storage using magnetic resonance imaging. Magnetic Resonance Imaging. 25(10). 1449–1458. 29 indexed citations
20.
Lodi, Alessia. (2006). Physico-chemical and molecular characterization of soy bread containing almond. OhioLink ETD Center (Ohio Library and Information Network). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026